Amongst sufferers with PD-1/PD-L1-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), remedy with buparlisib and paclitaxel was not related to an...
Amongst sufferers with operable, newly recognized mind metastases, remedy with GammaTile was related to a higher than 50% discount within the danger...
Including VCN-01 (zabilugene almadenorepvec) to standard-of-care (SOC) gemcitabine plus Abraxane (nab-paclitaxel) led to improved total survival (OS), progression-free survival (PFS), and length...
